Educational technology platform Abwaab secures $5.1 million in seed funding to expand regional presence
In the ever-evolving world of edtech, Abwaab, a startup based in Amman, has made significant strides in providing secondary school students across the Middle East and North Africa with a unique learning experience. The platform, which boasts a library of over 50 thousand video lessons and questions, all produced in-house, has recently raised $5.1 million in a seed round.
Founded in 2019 by former executives from Uber, Careem, and Mawdoo3, Abwaab offers an online platform that enables students to learn at their own pace. The platform is accessible to students in Jordan, Egypt, Saudi, and Palestine, and it provides video lessons, tutor interaction, tests, and quizzes.
The funds raised will be used to further expand Abwaab's reach across the region. The startup will be competing with Saudi's Noon Academy in many of its new markets.
In 2020, Abwaab made headlines when it collaborated with the Jordanian government to launch an online education platform, teaching over 1 million school-going students during the pandemic.
The investment in Abwaab was made by a consortium of investors, including 4DX Ventures, Beco Capital, EQ2 Ventures, Foundation Ventures, GSV Ventures, and Spartech Ventures. Hamdi Tabbaa, the CEO of KBW Investments, did not disclose the specific terms of the investment.
Abwaab operates on a freemium subscription model, offering some content for free and charging for full access. As the edtech landscape continues to grow, Abwaab is poised to make a significant impact in the region, providing accessible, high-quality education to students across the Middle East and North Africa.
Read also:
- visionary women of WearCheck spearheading technological advancements and catalyzing transformations
- A continuous command instructing an entity to halts all actions, repeated numerous times.
- Oxidative Stress in Sperm Abnormalities: Impact of Reactive Oxygen Species (ROS) on Sperm Harm
- Is it possible to receive the hepatitis B vaccine more than once?